U.S. Independent Diagnostic Testing Facility Market Size, Share & Trends Analysis Report By Service ((Radiology/Imaging Services, X-Ray, Computed Tomography (CT), Mammography, Ultrasound, Cardiac Monitoring Services, Sleep Studies), And Segment Forecasts, 2026 - 2033
The U.S. independent diagnostic testing facility market size was estimated at USD 10.08 billion in 2025 and is projected to reach USD 18.09 billion by 2033, growing at a CAGR of 7.66% from 2026 to 2033. The growth is driven by the growing burden of chronic and lifestyle-related diseases, rising preference for cost-efficient, accessible, and faster diagnostics, and increasing technological advancements, including digital imaging, AI-enabled diagnostics, portable diagnostics, and improved telehealth integration.
In addition, value-based healthcare initiatives and supportive reimbursement structures for certain diagnostic procedures are encouraging providers to shift services to independent diagnostic testing facilities.
U.S. Independent Diagnostic Testing Facility Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. independent diagnostic testing facility market report based on service:
In addition, value-based healthcare initiatives and supportive reimbursement structures for certain diagnostic procedures are encouraging providers to shift services to independent diagnostic testing facilities.
U.S. Independent Diagnostic Testing Facility Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. independent diagnostic testing facility market report based on service:
- Service Outlook (Revenue, USD Million, 2021 - 2033)
- Radiology/Imaging Services
- X-Ray
- Computed Tomography (CT)
- Magnetic Resonance Angiography (MRA)
- Magnetic Resonance Imaging (MRI)
- Mammography
- Ultrasound
- Positron Emission Tomography (PET) Scan
- Sleep Studies
- Cardiac Monitoring Services
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective -
1.8.2. Objective -
1.8.3. Objective -
1.9. List of Secondary Sources
1.10. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. U.S. Independent Diagnostic Testing Facility Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Service segment outlook
2.1.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.2.1. Market Dynamics
3.2.1.1. Market Driver Analysis
3.2.1.2. Market Restraint Analysis
3.2.1.3. Market Opportunities Analysis
3.2.1.4. Market Challenges Analysis
3.3. Regulatory Framework
3.4. Business Environment Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces Analysis
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
CHAPTER 4. SERVICE BUSINESS ANALYSIS
4.1. U.S. Independent Diagnostic Testing Facility Market: Service Movement Analysis
4.2. U.S. Independent Diagnostic Testing Facility Market: Service Segment Dashboard
4.3. Service Movement & Market Share Analysis, 2025 & 2033
4.4. U.S. Independent Diagnostic Testing Facility Market Estimates & Forecast, by Service
4.5. Radiology/Imaging Services
4.5.1. Radiology/imaging services market, 2021 - 2033 (USD Million)
4.5.2. X-Ray
4.5.2.1. X-ray market, 2021 - 2033 (USD Million)
4.5.3. Computed Tomography (CT)
4.5.3.1. Computed tomography (CT) market, 2021 - 2033 (USD Million)
4.5.4. Magnetic Resonance Angiography (MRA)
4.5.4.1. Magnetic resonance angiography (MRA) market, 2021 - 2033 (USD Million)
4.5.5. Magnetic Resonance Imaging (MRI)
4.5.5.1. Magnetic resonance imaging (MRI) market, 2021 - 2033 (USD Million)
4.5.6. Mammography
4.5.6.1. Mammography market, 2021 - 2033 (USD Million)
4.5.7. Ultrasound
4.5.7.1. Ultrasound market, 2021 - 2033 (USD Million)
4.5.8. Position Emission Tomography (PET) Scan
4.5.8.1. Position emission tomography (PET) scan market, 2021 - 2033 (USD Million)
4.6. Sleep Studies
4.6.1. Sleep studies market, 2021 - 2033 (USD Million)
4.7. Cardiac Monitoring Services
4.7.1. Cardiac monitoring services market, 2021 - 2033 (USD Million)
CHAPTER 5. COMPANY LANDSCAPE
5.1. Company Categorization
5.2. Company Market Position Analysis, 2025
5.3. Strategy Mapping
5.4. Company Profiles/Listing
5.4.1. RadNet, Inc.
5.4.1.1. Overview
5.4.1.2. Financial performance
5.4.1.3. Service benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Vitalistics
5.4.2.1. Overview
5.4.2.2. Financial performance
5.4.2.3. Service benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Breathe
5.4.3.1. Overview
5.4.3.2. Financial performance
5.4.3.3. Service benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Texas MRI
5.4.4.1. Overview
5.4.4.2. Financial performance
5.4.4.3. Service benchmarking
5.4.4.4. Strategic initiatives
5.4.5. The Brookwood Diagnostic Center
5.4.5.1. Overview
5.4.5.2. Financial performance
5.4.5.3. Service benchmarking
5.4.5.4. Strategic initiatives
5.4.6. ACS Diagnostics, Inc.
5.4.6.1. Overview
5.4.6.2. Financial performance
5.4.6.3. Service benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Houston MRI & Diagnostic Imaging
5.4.7.1. Overview
5.4.7.2. Financial performance
5.4.7.3. Service benchmarking
5.4.7.4. Strategic initiatives
5.4.8. TestSmarter Inc.
5.4.8.1. Overview
5.4.8.2. Financial performance
5.4.8.3. Service benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Duke University and Duke University Health System
5.4.9.1. Overview
5.4.9.2. Financial performance
5.4.9.3. Service benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Covenant Health Diagnostics
5.4.10.1. Overview
5.4.10.2. Financial performance
5.4.10.3. Service benchmarking
5.4.10.4. Strategic initiatives
5.4.11. AliveCor, Inc.
5.4.11.1. Overview
5.4.11.2. Financial performance
5.4.11.3. Service benchmarking
5.4.11.4. Strategic initiatives
5.4.12. Advanced Cardio Services
5.4.12.1. Overview
5.4.12.2. Financial performance
5.4.12.3. Service benchmarking
5.4.12.4. Strategic initiatives
5.4.13. Diagnostic Medical Testing Inc.
5.4.13.1. Overview
5.4.13.2. Financial performance
5.4.13.3. Service benchmarking
5.4.13.4. Strategic initiatives
5.4.14. K & T Diagnostic, Inc.
5.4.14.1. Overview
5.4.14.2. Financial performance
5.4.14.3. Service benchmarking
5.4.14.4. Strategic initiatives
5.4.15. Vestavia Diagnostic Center (VDC)
5.4.15.1. Overview
5.4.15.2. Financial performance
5.4.15.3. Service benchmarking
5.4.15.4. Strategic initiatives
5.4.16. Advanced Imaging Center
5.4.16.1. Overview
5.4.16.2. Financial performance
5.4.16.3. Service benchmarking
5.4.16.4. Strategic initiatives?
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective -
1.8.2. Objective -
1.8.3. Objective -
1.9. List of Secondary Sources
1.10. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. U.S. Independent Diagnostic Testing Facility Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Service segment outlook
2.1.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.2.1. Market Dynamics
3.2.1.1. Market Driver Analysis
3.2.1.2. Market Restraint Analysis
3.2.1.3. Market Opportunities Analysis
3.2.1.4. Market Challenges Analysis
3.3. Regulatory Framework
3.4. Business Environment Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces Analysis
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
CHAPTER 4. SERVICE BUSINESS ANALYSIS
4.1. U.S. Independent Diagnostic Testing Facility Market: Service Movement Analysis
4.2. U.S. Independent Diagnostic Testing Facility Market: Service Segment Dashboard
4.3. Service Movement & Market Share Analysis, 2025 & 2033
4.4. U.S. Independent Diagnostic Testing Facility Market Estimates & Forecast, by Service
4.5. Radiology/Imaging Services
4.5.1. Radiology/imaging services market, 2021 - 2033 (USD Million)
4.5.2. X-Ray
4.5.2.1. X-ray market, 2021 - 2033 (USD Million)
4.5.3. Computed Tomography (CT)
4.5.3.1. Computed tomography (CT) market, 2021 - 2033 (USD Million)
4.5.4. Magnetic Resonance Angiography (MRA)
4.5.4.1. Magnetic resonance angiography (MRA) market, 2021 - 2033 (USD Million)
4.5.5. Magnetic Resonance Imaging (MRI)
4.5.5.1. Magnetic resonance imaging (MRI) market, 2021 - 2033 (USD Million)
4.5.6. Mammography
4.5.6.1. Mammography market, 2021 - 2033 (USD Million)
4.5.7. Ultrasound
4.5.7.1. Ultrasound market, 2021 - 2033 (USD Million)
4.5.8. Position Emission Tomography (PET) Scan
4.5.8.1. Position emission tomography (PET) scan market, 2021 - 2033 (USD Million)
4.6. Sleep Studies
4.6.1. Sleep studies market, 2021 - 2033 (USD Million)
4.7. Cardiac Monitoring Services
4.7.1. Cardiac monitoring services market, 2021 - 2033 (USD Million)
CHAPTER 5. COMPANY LANDSCAPE
5.1. Company Categorization
5.2. Company Market Position Analysis, 2025
5.3. Strategy Mapping
5.4. Company Profiles/Listing
5.4.1. RadNet, Inc.
5.4.1.1. Overview
5.4.1.2. Financial performance
5.4.1.3. Service benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Vitalistics
5.4.2.1. Overview
5.4.2.2. Financial performance
5.4.2.3. Service benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Breathe
5.4.3.1. Overview
5.4.3.2. Financial performance
5.4.3.3. Service benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Texas MRI
5.4.4.1. Overview
5.4.4.2. Financial performance
5.4.4.3. Service benchmarking
5.4.4.4. Strategic initiatives
5.4.5. The Brookwood Diagnostic Center
5.4.5.1. Overview
5.4.5.2. Financial performance
5.4.5.3. Service benchmarking
5.4.5.4. Strategic initiatives
5.4.6. ACS Diagnostics, Inc.
5.4.6.1. Overview
5.4.6.2. Financial performance
5.4.6.3. Service benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Houston MRI & Diagnostic Imaging
5.4.7.1. Overview
5.4.7.2. Financial performance
5.4.7.3. Service benchmarking
5.4.7.4. Strategic initiatives
5.4.8. TestSmarter Inc.
5.4.8.1. Overview
5.4.8.2. Financial performance
5.4.8.3. Service benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Duke University and Duke University Health System
5.4.9.1. Overview
5.4.9.2. Financial performance
5.4.9.3. Service benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Covenant Health Diagnostics
5.4.10.1. Overview
5.4.10.2. Financial performance
5.4.10.3. Service benchmarking
5.4.10.4. Strategic initiatives
5.4.11. AliveCor, Inc.
5.4.11.1. Overview
5.4.11.2. Financial performance
5.4.11.3. Service benchmarking
5.4.11.4. Strategic initiatives
5.4.12. Advanced Cardio Services
5.4.12.1. Overview
5.4.12.2. Financial performance
5.4.12.3. Service benchmarking
5.4.12.4. Strategic initiatives
5.4.13. Diagnostic Medical Testing Inc.
5.4.13.1. Overview
5.4.13.2. Financial performance
5.4.13.3. Service benchmarking
5.4.13.4. Strategic initiatives
5.4.14. K & T Diagnostic, Inc.
5.4.14.1. Overview
5.4.14.2. Financial performance
5.4.14.3. Service benchmarking
5.4.14.4. Strategic initiatives
5.4.15. Vestavia Diagnostic Center (VDC)
5.4.15.1. Overview
5.4.15.2. Financial performance
5.4.15.3. Service benchmarking
5.4.15.4. Strategic initiatives
5.4.16. Advanced Imaging Center
5.4.16.1. Overview
5.4.16.2. Financial performance
5.4.16.3. Service benchmarking
5.4.16.4. Strategic initiatives?
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. independent diagnostic testing facility market revenue estimates and forecast, by service, 2021 - 2033 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. independent diagnostic testing facility market revenue estimates and forecast, by service, 2021 - 2033 (USD Million)
LIST OF FIGURES
Fig. 1 U.S. independent diagnostic testing facility market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Competitive landscape
Fig. 11 U.S. independent diagnostic testing facility market trends & outlook
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 U.S. independent diagnostic testing facility market: Service movement share analysis (USD Million)
Fig. 16 U.S independent diagnostic testing facility service market: Segment dashboard
Fig. 17 Radiology/Imaging testing market, 2021 - 2033 (USD Million)
Fig. 18 X-Ray market, 2021 - 2033 (USD Million)
Fig. 19 Computed tomography (CT) market, 2021 - 2033 (USD Million)
Fig. 20 Magnetic resonance angiography (MRA) market, 2021 - 2033 (USD Million)
Fig. 21 Magnetic resonance imaging (MRI) market, 2021 - 2033 (USD Million)
Fig. 22 Mammography market, 2021 - 2033 (USD Million)
Fig. 23 Ultrasound market, 2021 - 2033 (USD Million)
Fig. 24 Positron emission tomography (PET) Scan. 2021 - 2033 (USD Million)
Fig. 25 Sleep studies market, 2021 - 2033 (USD Million)
Fig. 26 Cardiac monitoring services market, 2021 - 2033 (USD Million)
Fig. 27 Competition categorization
Fig. 28 Company market position analysis, 2025
Fig. 29 Strategic framework
Fig. 1 U.S. independent diagnostic testing facility market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Competitive landscape
Fig. 11 U.S. independent diagnostic testing facility market trends & outlook
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 U.S. independent diagnostic testing facility market: Service movement share analysis (USD Million)
Fig. 16 U.S independent diagnostic testing facility service market: Segment dashboard
Fig. 17 Radiology/Imaging testing market, 2021 - 2033 (USD Million)
Fig. 18 X-Ray market, 2021 - 2033 (USD Million)
Fig. 19 Computed tomography (CT) market, 2021 - 2033 (USD Million)
Fig. 20 Magnetic resonance angiography (MRA) market, 2021 - 2033 (USD Million)
Fig. 21 Magnetic resonance imaging (MRI) market, 2021 - 2033 (USD Million)
Fig. 22 Mammography market, 2021 - 2033 (USD Million)
Fig. 23 Ultrasound market, 2021 - 2033 (USD Million)
Fig. 24 Positron emission tomography (PET) Scan. 2021 - 2033 (USD Million)
Fig. 25 Sleep studies market, 2021 - 2033 (USD Million)
Fig. 26 Cardiac monitoring services market, 2021 - 2033 (USD Million)
Fig. 27 Competition categorization
Fig. 28 Company market position analysis, 2025
Fig. 29 Strategic framework
